Prelude Capital Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,300
Closed -$278K 1252
2025
Q1
$278K Sell
7,300
-2,700
-27% -$100K 0.02% 737
2024
Q4
$379K Sell
10,000
-4,700
-32% -$188K 0.02% 700
2024
Q3
$598K Sell
14,700
-200
-1% -$7.57K 0.04% 554
2024
Q2
$510K Sell
14,900
-9,700
-39% -$306K 0.04% 537
2024
Q1
$779K Sell
24,600
-4,100
-14% -$125K 0.04% 465
2023
Q4
$880K Hold
28,700
0.06% 323
2023
Q3
$952K Buy
28,700
+4,700
+20% +$150K 0.06% 314
2023
Q2
$737K Sell
24,000
-6,500
-21% -$188K 0.05% 360
2023
Q1
$836K Sell
30,500
-2,400
-7% -$66.8K 0.05% 340
2022
Q4
$920K Buy
+32,900
New +$992K 0.05% 406
2019
Q1
Sell
-24,600
Closed -$865K 2051
2018
Q4
$865K Sell
24,600
-53,300
-68% -$1.85M 0.06% 347
2018
Q3
$2.55M Buy
77,900
+51,300
+193% +$1.63M 0.15% 140
2018
Q2
$825K Buy
+26,600
New +$760K 0.05% 383

Other funds holding OHI

Prelude Capital Management's OHI Position: Q2 2026 in Review

Prelude Capital Management sold out of Omega Healthcare (OHI) in Q2 2026, closing a stake of 9,053 shares — an estimated $397K sold.

Prelude Capital Management first reported a position in OHI in Q3 2013 and held it in 12 quarters. The position peaked at $526K in Q4 2019. 762 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Prelude Capital Management reported no remaining Omega Healthcare position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 9,053 Omega Healthcare shares in Q2 2026, an estimated $397K.
  • Prelude Capital Management first reported a position in Omega Healthcare in Q3 2013 and held it in 12 quarters.
  • Prelude Capital Management's Omega Healthcare position peaked at $526K in Q4 2019.
  • 762 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.